Primary and Urgent Care LLC
Primary and Urgent Care LLC was paid $9.19M by Medicaid between Jan 2018 and Dec 2024, across 57 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoPRIMARY AND URGENT CARE LLC
STAFFORD, VA 22554
STAFFORD, VA 22554
33aNPI1316018781assigned 11/10/2006
33bProvider typeSpecialist
28Total paid$9.19M
24GClaims249,799
24DCodes billed57
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Virginia
Rank by total paid#4 of 231
Median peer was paid$47K
This provider vs. median195×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,715 | $489K | |
| 2019 | 30,993 | $1.07M | |
| 2020 | 30,267 | $1.12M | |
| 2021 | 35,756 | $1.39M | |
| 2022 | 42,155 | $1.72M | |
| 2023 | 50,659 | $1.90M | |
| 2024incomplete | 44,254 | $1.50M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 43,115 | 38,550 | $3.27M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 41,629 | 36,672 | $2.15M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 14,188 | 13,541 | $1.03M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.0% | 22,678 | 20,728 | $643K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.9% | 5,885 | 5,538 | $639K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.9% | 34,213 | 20,511 | $541K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.5% | 18,487 | 17,099 | $227K |
| 87428 | 1.2% | 2,376 | 2,286 | $109K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 7,996 | 6,275 | $93K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 732 | 689 | $71K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,797 | 8,892 | $63K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 530 | 519 | $44K |
45 more codes
| 80053 | Comprehensive metabolic panel | <1% | 5,241 | $36K |
| 80061 | Lipid panel | <1% | 2,987 | $27K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 318 | $26K |
| 99384 | <1% | 230 | $22K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,436 | $19K |
| 81003 | <1% | 11,589 | $16K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 4,501 | $15K |
| 99383 | <1% | 176 | $15K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 280 | $14K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,019 | $13K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 354 | $12K |
| 87807 | <1% | 897 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,660 | $10K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 452 | $9K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 108 | $7K |
| 0011A | <1% | 187 | $6K | |
| 81025 | <1% | 957 | $6K | |
| 0012A | <1% | 175 | $6K | |
| 0001A | <1% | 133 | $5K | |
| 0002A | <1% | 127 | $5K | |
| 94644 | <1% | 119 | $4K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 15 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,121 | $4K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 43 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,838 | $3K |
| 93000 | <1% | 168 | $2K | |
| 0013A | <1% | 39 | $1K | |
| 73562 | <1% | 53 | $1K | |
| 72110 | <1% | 27 | $1K | |
| 0003A | <1% | 28 | $1K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 81 | $955.80 |
| 73610 | <1% | 26 | $783.07 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 210 | $612.98 |
| 99305 | <1% | 16 | $407.49 | |
| 73030 | <1% | 14 | $391.99 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 243 | $391.60 |
| 73130 | <1% | 12 | $377.49 | |
| 73630 | <1% | 12 | $307.67 | |
| 82570 | <1% | 101 | $272.05 | |
| 82044 | <1% | 99 | $264.77 | |
| 99406 | <1% | 25 | $231.80 | |
| 86328 | <1% | 14 | $208.06 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 13 | $10.70 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 14 | $0.42 |
| Q0240 | Injection, casirivimab and imdevimab, 600 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANSARI, NATHER (OWNER)